Substantia nigra depigmentation and exposure to encephalitis lethargica

Annals of Neurology

Volumn 72, Issue 6, 2012, Pages 912-917

  Hack, Nawaz ^a   Jicha, Gregory A ^a,b   Abell, Annalisa ^b   Dean, Dawson ^b   Vitek, Jerrold L ^c   Berger, Joseph R ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; ARTICLE; AUTOPSY; COHORT ANALYSIS; CONTROLLED STUDY; DEPIGMENTATION; EPIDEMIC ENCEPHALITIS; EXPOSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MOTOR COORDINATION; PARKINSONISM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STEREOMETRY; SUBSTANTIA NIGRA; WALKING SPEED;

AGED, 80 AND OVER; COHORT STUDIES; ENCEPHALITIS; FEMALE; HAND; HUMANS; KAPLAN-MEIER ESTIMATE; LETHARGY; LOCOMOTION; MALE; PARKINSON DISEASE; PSYCHOMOTOR PERFORMANCE; RETROSPECTIVE STUDIES; SUBSTANTIA NIGRA;

EID: 84871964782     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.23697     Document Type: Article

References (36)

1. Hardy J, Cai H, Cookson MR, et al. Genetics of Parkinson's disease and parkinsonism. Ann Neurol 2006; 60: 389-398. (Pubitemid 44684974)
2. de Lau LM, Breteler MM,. Epidemiology of Parkinson's disease. Lancet Neurol 2006; 5: 525-535. (Pubitemid 44262284)
3. Stoessl AJ,. Etiology of Parkinson's disease. Can J Neurol Sci 1999; 26 (suppl 2): S5-S12. (Pubitemid 29378960)
4. von Economo C,. Encephalitis lethargica: its sequelae and treatment. London, UK: Oxford University Press, 1931.
5. Urechia CL,. Dix cas d'encephalite epidemique avec autopsie. Arch Int Neurol 1921; 2: 65-78.
6. Berger JR, Glitza IC,. Von Economo's encephalitis. In:, Nath A, Berger JR, eds. Clinical neurovirology. New York, NY: Marcel Dekker, 2003: 523-542.
7. Wilson SAK,. Epidemic encephalitis. Neurology 1940; 1: 99-144.
8. McCall S, Henry JM, Reid AH, Taubenberger JK,. Influenza RNA not detected in archival brain tissues from acute encephalitis lethargica cases or in postencephalitic Parkinson cases. J Neuropathol Exp Neurol 2001; 60: 696-704. (Pubitemid 32619792)
9. Jellinger KA,. Influenza RNA not detected in archival brain tissues from acute encephalitis lethargica cases or in postencephalitic Parkinson cases. J Neuropathol Exp Neurol 2001; 60: 1121-1122.
10. Poskanzer DC, Schwab RS,. Studies in the epidemiology of Parkinson's disease predicting its disappearance as a major clinical entity by 1980. Trans Am Neurol Assoc 1961; 86: 234-235.
11. Lipczynska-Lojkowska W,. Etiology of parkinsonism. A verification of Poskanzer's and Schwab's hypothesis [in Polish]. Neurol Neurochir Pol 1979; 13: 593-599. (Pubitemid 10185713)
12. Morris S, Morris ME, Iansek R,. Reliability of measurements obtained with the Timed "Up & Go" test in people with Parkinson disease. Phys Ther 2001; 81: 810-818. (Pubitemid 32119065)
13. Hixson JE, Vernier DT,. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31: 545-548. (Pubitemid 20107994)
14. Iacono D, Markesbery WR, Gross M, et al. The Nun Study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life. Neurology 2009; 73: 665-673.
15. Yamamoto T, Hirano A,. A comparative study of modified Bielschowsky, Bodian and thioflavin S stains on Alzheimer's neurofibrillary tangles. Neuropathol Appl Neurobiol 1986; 12: 3-9. (Pubitemid 16168220)
16. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-486.
17. Braak H, Braak E,. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991; 82: 239-259.
18. Jang H, Boltz DA, Webster RG, Smeyne RJ,. Viral parkinsonism. Biochim Biophys Acta 2009; 1792: 714-721.
19. Rohn TT, Catlin LW,. Immunolocalization of influenza A virus and markers of inflammation in the human Parkinson's disease brain. PLoS One 2011; 6: e20495.
20. Arai H, Furuya T, Mizuno Y, Mochizuki H,. Inflammation and infection in Parkinson's disease. Histol Histopathol 2006; 21: 673-678.
21. Liu B, Gao HM, Hong JS,. Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. Environ Health Perspect 2003; 111: 1065-1073. (Pubitemid 36826886)
22. Furuya T, Hayakawa H, Yamada M, et al. Caspase-11 mediates inflammatory dopaminergic cell death in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. J Neurosci 2004; 24: 1865-1872. (Pubitemid 38292797)
23. Carvey PM, Chang Q, Lipton JW, Ling Z,. Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease. Front Biosci 2003; 8: s826-s837. (Pubitemid 39140200)
24. Dale RC, Church AJ, Surtees RA, et al. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain 2004; 127 (pt 1): 21-33. (Pubitemid 38055343)
25. Cree BC, Bernardini GL, Hays AP, Lowe G,. A fatal case of coxsackievirus B4 meningoencephalitis. Arch Neurol 2003; 60: 107-112. (Pubitemid 36078116)
26. Roselli F, Russo I, Fraddosio A, et al. Reversible Parkinsonian syndrome associated with anti-neuronal antibodies in acute EBV encephalitis: a case report. Parkinsonism Relat Disord 2006; 12: 257-260. (Pubitemid 43737240)
27. Dimova PS, Bojinova V, Georgiev D, Milanov I,. Acute reversible parkinsonism in Epstein-Barr virus-related encephalitis lethargica-like illness. Mov Disord 2006; 21: 564-566.
28. Hsieh JC, Lue KH, Lee YL,. Parkinson-like syndrome as the major presenting symptom of Epstein-Barr virus encephalitis. Arch Dis Child 2002; 87: 358.
29. Murgod UA, Muthane UB, Ravi V, et al. Persistent movement disorders following Japanese encephalitis. Neurology 2001; 57: 2313-2315. (Pubitemid 34016472)
30. Hersh BP, Rajendran PR, Battinelli D,. Parkinsonism as the presenting manifestation of HIV infection: improvement on HAART. Neurology 2001; 56: 278-279. (Pubitemid 32095382)
31. Mattos JP, Rosso AL, Correa RB, Novis SA,. Movement disorders in 28 HIV-infected patients. Arq Neuropsiquiatr 2002; 60: 525-530.
32. Nath A, Jankovic J, Pettigrew LC,. Movement disorders and AIDS. Neurology 1987; 37: 37-41. (Pubitemid 17230105)
33. Berger JR, Arendt G,. HIV dementia: the role of the basal ganglia and dopaminergic systems. J Psychopharmacol 2000; 14: 214-221.
34. Alasia DD, Asekomeh GA, Unachuku CN,. Parkinsonism induced by sepsis: a case report. Niger J Med 2006; 15: 333-336.
35. Wszolek Z, Monsour H, Smith P, Pfeiffer R,. Cryptococcal meningoencephalitis with parkinsonian features. Mov Disord 1988; 3: 271-273.
36. Jicha GA, Parisi JE, Dickson DW, et al. Age and apoE associations with complex pathologic features in Alzheimer's disease. J Neurol Sci 2008; 273: 34-39.